vs

Side-by-side financial comparison of Celsius Holdings, Inc. (CELH) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $721.6M, roughly 1.7× Celsius Holdings, Inc.). Dexcom runs the higher net margin — 21.2% vs 3.4%, a 17.8% gap on every dollar of revenue. On growth, Celsius Holdings, Inc. posted the faster year-over-year revenue change (117.2% vs 21.6%). Over the past eight quarters, Celsius Holdings, Inc.'s revenue compounded faster (42.4% CAGR vs 12.0%).

Celsius Holdings, Inc. is an American company that produces a range of fitness and energy drinks under the brand name Celsius. The company's products are marketed as healthy, to which the CEO attributes the brand's success.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

CELH vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.7× larger
DXCM
$1.3B
$721.6M
CELH
Growing faster (revenue YoY)
CELH
CELH
+95.6% gap
CELH
117.2%
21.6%
DXCM
Higher net margin
DXCM
DXCM
17.8% more per $
DXCM
21.2%
3.4%
CELH
Faster 2-yr revenue CAGR
CELH
CELH
Annualised
CELH
42.4%
12.0%
DXCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CELH
CELH
DXCM
DXCM
Revenue
$721.6M
$1.3B
Net Profit
$24.7M
$267.3M
Gross Margin
47.4%
62.9%
Operating Margin
3.6%
25.6%
Net Margin
3.4%
21.2%
Revenue YoY
117.2%
21.6%
Net Profit YoY
231.1%
153.6%
EPS (diluted)
$0.04
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CELH
CELH
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$721.6M
$1.3B
Q3 25
$725.1M
$1.2B
Q2 25
$739.3M
$1.2B
Q1 25
$329.3M
$1.0B
Q4 24
$332.2M
$1.1B
Q3 24
$265.7M
$994.2M
Q2 24
$402.0M
$1.0B
Net Profit
CELH
CELH
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$24.7M
$267.3M
Q3 25
$-61.0M
$283.8M
Q2 25
$99.9M
$179.8M
Q1 25
$44.4M
$105.4M
Q4 24
$-18.9M
$151.7M
Q3 24
$6.4M
$134.6M
Q2 24
$79.8M
$143.5M
Gross Margin
CELH
CELH
DXCM
DXCM
Q1 26
62.9%
Q4 25
47.4%
62.9%
Q3 25
51.3%
60.5%
Q2 25
51.5%
59.5%
Q1 25
52.3%
56.9%
Q4 24
50.2%
58.9%
Q3 24
46.0%
59.7%
Q2 24
52.0%
62.4%
Operating Margin
CELH
CELH
DXCM
DXCM
Q1 26
25.6%
Q4 25
3.6%
25.6%
Q3 25
-11.0%
20.1%
Q2 25
19.3%
18.4%
Q1 25
15.8%
12.9%
Q4 24
-5.6%
17.0%
Q3 24
-1.2%
15.3%
Q2 24
23.4%
15.7%
Net Margin
CELH
CELH
DXCM
DXCM
Q1 26
21.2%
Q4 25
3.4%
21.2%
Q3 25
-8.4%
23.5%
Q2 25
13.5%
15.5%
Q1 25
13.5%
10.2%
Q4 24
-5.7%
13.6%
Q3 24
2.4%
13.5%
Q2 24
19.8%
14.3%
EPS (diluted)
CELH
CELH
DXCM
DXCM
Q1 26
$0.67
Q4 25
$0.04
$0.67
Q3 25
$-0.27
$0.70
Q2 25
$0.33
$0.45
Q1 25
$0.15
$0.27
Q4 24
$-0.10
$0.37
Q3 24
$0.00
$0.34
Q2 24
$0.28
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CELH
CELH
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$398.9M
$917.7M
Total DebtLower is stronger
$676.9M
Stockholders' EquityBook value
$1.2B
$2.7B
Total Assets
$5.1B
$6.3B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CELH
CELH
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$398.9M
$917.7M
Q3 25
$806.0M
$1.8B
Q2 25
$615.2M
$1.2B
Q1 25
$977.3M
$904.9M
Q4 24
$890.2M
$606.1M
Q3 24
$903.7M
$621.2M
Q2 24
$903.2M
$939.2M
Total Debt
CELH
CELH
DXCM
DXCM
Q1 26
Q4 25
$676.9M
Q3 25
$870.5M
Q2 25
$871.9M
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CELH
CELH
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$1.2B
$2.7B
Q3 25
$1.2B
$2.7B
Q2 25
$1.3B
$2.6B
Q1 25
$443.1M
$2.3B
Q4 24
$399.9M
$2.1B
Q3 24
$423.6M
$2.0B
Q2 24
$415.8M
$2.4B
Total Assets
CELH
CELH
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$5.1B
$6.3B
Q3 25
$5.3B
$7.5B
Q2 25
$3.8B
$7.3B
Q1 25
$1.9B
$6.8B
Q4 24
$1.8B
$6.5B
Q3 24
$1.7B
$6.4B
Q2 24
$1.7B
$6.8B
Debt / Equity
CELH
CELH
DXCM
DXCM
Q1 26
Q4 25
0.57×
Q3 25
0.72×
Q2 25
0.69×
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CELH
CELH
DXCM
DXCM
Operating Cash FlowLast quarter
$-119.4M
Free Cash FlowOCF − Capex
$-130.0M
FCF MarginFCF / Revenue
-18.0%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
-4.83×
TTM Free Cash FlowTrailing 4 quarters
$323.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CELH
CELH
DXCM
DXCM
Q1 26
Q4 25
$-119.4M
$294.0M
Q3 25
$331.8M
$659.9M
Q2 25
$43.7M
$303.0M
Q1 25
$103.4M
$183.8M
Q4 24
$75.7M
$301.4M
Q3 24
$12.9M
$199.5M
Q2 24
$39.6M
$279.4M
Free Cash Flow
CELH
CELH
DXCM
DXCM
Q1 26
Q4 25
$-130.0M
$192.1M
Q3 25
$321.5M
$579.4M
Q2 25
$35.5M
$208.9M
Q1 25
$96.4M
$96.8M
Q4 24
$70.3M
$176.8M
Q3 24
$8.7M
$88.3M
Q2 24
$30.4M
$213.3M
FCF Margin
CELH
CELH
DXCM
DXCM
Q1 26
Q4 25
-18.0%
15.3%
Q3 25
44.3%
47.9%
Q2 25
4.8%
18.1%
Q1 25
29.3%
9.3%
Q4 24
21.2%
15.9%
Q3 24
3.3%
8.9%
Q2 24
7.6%
21.2%
Capex Intensity
CELH
CELH
DXCM
DXCM
Q1 26
Q4 25
1.5%
8.1%
Q3 25
1.4%
6.7%
Q2 25
1.1%
8.1%
Q1 25
2.1%
8.4%
Q4 24
1.6%
11.2%
Q3 24
1.6%
11.2%
Q2 24
2.3%
6.6%
Cash Conversion
CELH
CELH
DXCM
DXCM
Q1 26
Q4 25
-4.83×
1.10×
Q3 25
2.33×
Q2 25
0.44×
1.69×
Q1 25
2.33×
1.74×
Q4 24
1.99×
Q3 24
2.03×
1.48×
Q2 24
0.50×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons